Yanling Pei Selected Research

prim-O-glucosylcimifugin

4/2022

Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanling Pei Research Topics

Disease

1	COVID-19 04/2022
1	Asthma (Bronchial Asthma) 04/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2022
1	Atherosclerosis 04/2022
1	Pneumonia (Pneumonitis) 04/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022
1	Chagas Disease (American Trypanosomiasis) 04/2022
1	Paraplegia (Spastic Paraplegia) 01/2017
1	Neoplasms (Cancer) 06/2013

Drug/Important Bio-Agent (IBA)

1	5-O-methylvisamminolIBA 04/2022
1	astragaloside AIBA 04/2022
1	wogoninIBA 04/2022
1	prim-O-glucosylcimifuginIBA 04/2022
1	yupingfengIBA 04/2022
1	CytokinesIBA 04/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2022
1	Interleukin-17 (Interleukin 17)IBA 04/2022
1	Mitogen-Activated Protein Kinase 14IBA 04/2022
1	Nonprescription Drugs (Patent Medicines)IBA 04/2022
1	LigandsIBA 04/2022
1	LipidsIBA 04/2022
1	PowdersIBA 04/2022
1	Interleukin-6 (Interleukin 6)IBA 04/2022
1	Contrast MediaIBA 06/2013
1	Pharmaceutical PreparationsIBA 06/2013
1	Fluorescein-5-isothiocyanate (FITC)IBA 06/2013

Therapy/Procedure

1	Orthotic Devices (Orthosis) 01/2017